Latanoprost/Timolol Ingen Pharma

Timolol Maleate and Latanoprost, the active ingredients in Latanoprost/Timolol Ingen Pharma, are a beta‑blocker and a prostaglandin analog presented as an ophthalmic solution for ocular (topical) use. It treats open‑angle glaucoma and ocular hypertension in adults.

GNH USA supplies Latanoprost/Timolol Ingen Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost/Timolol is indicated for conditions affecting intra‑ocular pressure within the glaucoma and ocular hypertension disease family. - Open‑angle glaucoma: lowers intra‑ocular pressure to prevent optic‑nerve damage. - Ocular hypertension: reduces eye pressure to lower the risk of progression to glaucoma. - Elevated intra‑ocular pressure: improves aqueous‑humor outflow to maintain normal pressure levels.

The most frequently reported ocular reactions are generally mild and transient.

Common Side Effects: - Eye irritation or burning sensation. - Blurred vision shortly after instillation. - Conjunctival hyperemia (eye redness). - Increased eyelash length or thickness. - Darkening of the iris color. - Foreign‑body sensation in the eye.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angio‑edema, anaphylaxis). - Marked bradycardia or heart block. - Bronchospasm or severe asthma exacerbation. - Persistent ocular pain or inflammation. - Systemic hypotension with dizziness. - Vision loss due to acute angle‑closure glaucoma.

Before initiating therapy, clinicians should evaluate relevant systemic and ocular factors. - Cardiac assessment: review history of bradycardia, heart block, or heart failure. - Respiratory evaluation: avoid in patients with severe asthma or chronic obstructive pulmonary disease. - Ocular surgery: discontinue before intra‑ocular procedures to prevent wound‑healing complications. - Pregnancy and lactation: use only if potential benefit justifies potential risk. - Concomitant beta‑blockers: monitor for additive systemic beta‑blockade effects. - Store at room temperature: keep bottle tightly closed, protect from light and freezing.

Latanoprost/Timolol may interact with other systemic or ocular agents, requiring careful management.

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers (e.g., propranolol): risk of profound bradycardia and hypotension. - Inhaled or oral beta‑agonists for asthma: antagonism may worsen bronchospasm. - Other topical prostaglandin analogues: additive ocular irritation.

Moderate Interactions (Monitor Closely):\n- Calcium‑channel blockers: may enhance timolol‑induced cardiac effects. - Anticholinergic eye drops: possible reduction in ocular surface lubrication. - Systemic antihypertensives: monitor blood pressure for additive lowering. - NSAIDs: may interfere with prostaglandin‑mediated outflow mechanisms.